Molbio Diagnostics Limited (NSE:MOLBIO)

Market Cap	151.33B
Revenue (ttm)	17.54B +109.7%
Net Income	2.49B +144.3%
EPS	22.09 +144.4%
Shares Out	115.24M
PE Ratio	59.44
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	133,669
Open	1,304.20
Previous Close	1,313.20
Day's Range	1,288.80 - 1,321.60
52-Week Range	807.00 - 1,686.80
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 5, 2026

About Molbio Diagnostics

Molbio Diagnostics Limited, a point-of-care diagnostics company, provides healthcare technologies to diagnose infectious and non-communicable diseases. It manufactures and sells chip based diagnostic devices, chips and reagents, X-ray equipment's, and single/dual detectors. It also offers disposable POCT devices, which includes dengue, malaria, and COVID-19 tests; Tabletop analysers, a portable machine that are used to perform molecular or immunodiagnostic tests to detect infectious diseases, such as tuberculosis, human papillomavrus, STIs, and...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2000
• Employees: 1,225
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: MOLBIO

Financial Performance

In fiscal year 2026, Molbio Diagnostics's revenue was 14.46 billion, an increase of 41.68% compared to the previous year's 10.20 billion. Earnings were 1.67 billion, an increase of 14.81%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Sep 24, 2026

Data Sources Report a data error